PharmaTher Signs License Agreement for Patented Ketamine Treatment Jan 22 • 3 min read PharmaTher has entered an agreement with the National Health Research Institutes of Taiwan to develop and commercialize a patented formulation of FDA-approved ketamine and betaine combination called KETABET.
Mydecine Innovations Group Included in First-Ever Psychedelics ETF Jan 22 • 3 min read Mydecine Innovations Group has been included in the first-ever Psychedelics Exchanged Traded Fund (ETF).
Revive Therapeutics Announces $10 Million Bought Deal Offering of Units Jan 21 • 5 min read Revive Therapeutics Ltd. announced that is has entered into an agreement with underwriters have agreed to purchase 20,000,000 units at a price of $0.50 per equity unit for gross proceeds to the company of $10,000,000.
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD Jan 20 • 4 min read MindMed announced today the start of the first ever clinical trial measuring and evaluating MDMA and LSD used in combination in the human body.
Better Plant Affiliate NeonMind Lists on the Frankfurt Stock Exchange (FSE: 6UF) Jan 19 • 3 min read Better Plant Sciences Inc. announced its partially owned subsidiary NeonMind has common shares now trading on the Frankfurt Stock Exchange under the symbol “6UF“.